Central neural regulation of cardiovascular function by angiotensin: a focus on the rostral ventrolateral medulla. 2009

Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
Department of Physiology, University of Melbourne, and Howard Florey Institute, Melbourne, Vic., Australia. a.allen@unimelb.edu.au

Angiotensin II acts through specific receptors to alter several brain functions including fluid and electrolyte control, neuroendocrine function and autonomic efferent activity. This review discusses one brain site, the rostral ventrolateral medulla, where the actions of angiotensin II have been intensively studied. The rostral ventrolateral medulla plays a critical role in the generation and regulation of sympathetic activity to the cardiovascular system and hence is important for blood pressure control. Current evidence indicates that angiotensin II activates neurons in the rostral ventrolateral medulla via the AT(1A) receptor. In some models of cardiovascular disease, blockade of AT(1) receptors in the rostral ventrolateral medulla reduces sympathetic nerve activity and blood pressure suggesting that overactivity of the angiotensin system in this nucleus may play a role in the maintenance of high blood pressure.

UI MeSH Term Description Entries
D008526 Medulla Oblongata The lower portion of the BRAIN STEM. It is inferior to the PONS and anterior to the CEREBELLUM. Medulla oblongata serves as a relay station between the brain and the spinal cord, and contains centers for regulating respiratory, vasomotor, cardiac, and reflex activities. Accessory Cuneate Nucleus,Ambiguous Nucleus,Arcuate Nucleus of the Medulla,Arcuate Nucleus-1,External Cuneate Nucleus,Lateral Cuneate Nucleus,Nucleus Ambiguus,Ambiguus, Nucleus,Arcuate Nucleus 1,Arcuate Nucleus-1s,Cuneate Nucleus, Accessory,Cuneate Nucleus, External,Cuneate Nucleus, Lateral,Medulla Oblongatas,Nucleus, Accessory Cuneate,Nucleus, Ambiguous,Nucleus, External Cuneate,Nucleus, Lateral Cuneate
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000809 Angiotensins Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized. Angiotensin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
April 2009, Molecular and cellular endocrinology,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
October 2003, Cellular and molecular neurobiology,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
November 1991, European journal of pharmacology,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
January 1996, Clinical and experimental pharmacology & physiology. Supplement,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
September 1996, Clinical and experimental pharmacology & physiology,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
November 1984, The Journal of pharmacology and experimental therapeutics,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
June 2007, Current hypertension reports,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
January 1989, Progress in brain research,
Andrew M Allen, and E L O'Callaghan, and D Chen, and J K Bassi
January 2017, Frontiers in physiology,
Copied contents to your clipboard!